ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,300,000 | +100.9% | 68,923 | +25.5% | 0.00% | +100.0% |
| Q2 2019 | $647,000 | -38.1% | 54,912 | -46.2% | 0.00% | 0.0% |
| Q4 2018 | $1,045,000 | +301.9% | 101,993 | +553.7% | 0.00% | – |
| Q3 2018 | $260,000 | +17.6% | 15,603 | -13.5% | 0.00% | – |
| Q3 2017 | $221,000 | -62.7% | 18,038 | -0.4% | 0.00% | -100.0% |
| Q3 2016 | $593,000 | -68.6% | 18,109 | -76.5% | 0.00% | -66.7% |
| Q1 2016 | $1,887,000 | +331.8% | 77,044 | +482.7% | 0.00% | +200.0% |
| Q4 2015 | $437,000 | -5.6% | 13,223 | -6.4% | 0.00% | 0.0% |
| Q3 2015 | $463,000 | -76.8% | 14,130 | -62.5% | 0.00% | -66.7% |
| Q2 2015 | $1,998,000 | -3.1% | 37,724 | -47.2% | 0.00% | 0.0% |
| Q1 2015 | $2,062,000 | +623.5% | 71,458 | +628.4% | 0.00% | – |
| Q4 2014 | $285,000 | – | 9,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |